Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | CHKA | P35790 | 7/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL3361424 | 0.98 | ALDH1A1 (0.51) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| SCHEMBL17384186 | 0.95 | ALDH1A1 (0.49) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| SCHEMBL1226951 | 0.84 | MEN1 (0.39) | ALDH1A1KDM4ERAB9ALMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL193019 | 0.84 | BCHE (0.40) | ALDH1A1KDM4ERAB9AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL602361 | 0.83 | S1PR2 (0.48) | ALDH1A1KDM4ERAB9A | |
| Bromide SCHEMBL918125 | 0.82 | MEN1 (0.38) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Hydrochloric Acid SCHEMBL210855 | 0.82 | MEN1 (0.38) | ALDH1A1KDM4ERAB9ALMNASMN1; SMN2 | |
| SCHEMBL13851324 | 0.81 | CHKA (0.58) | ALDH1A1CHKALMNASMN1; SMN2HTT | |
| Benzyl Viologen SCHEMBL1108041 | 0.80 | ALDH1A1 (0.74) | ALDH1A1KDM4ERAB9ACHKALMNA | |
| Benzyl Viologen SCHEMBL1930045 | 0.78 | ALDH1A1 (0.78) | ALDH1A1KDM4ERAB9ACHKALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015193301-A1 | AN ELECTROCHROMIC MATERIAL, AND AN ELECTROCHROMIC PARTICLE AND AN ELECTROCHROMIC DEVICE COMPRISING THE SAME | IRIDOS LTD. (KR) | 2015-12-23 | — | — | WO | disclosed |
| US-20090137807-A1 | Electrochromic material with improved lifetime | LG CHEM, LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-7521005-B2 | Electrochromic material with improved lifetime | LG CHEM, LTD. (KR) | 2009-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137807-A1 | Electrochromic material with improved lifetime | CCNE2, NFE2L2, NQO1 | ALDH1A1 3177/4885KDM4E 445/4885RAB9A 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.